Macoin, J., Lissilaa, R., Sancheti, P., Reddy, V., Back, J. and Wolff, G. (2018) “Targeting OX40 With GBR 830, An OX40 Antagonist, Inhibits T Cell-Mediated Pathological Responses”, SKIN The Journal of Cutaneous Medicine, 2, p. S62. doi: 10.25251/skin.2.62.